Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cryo Cell International (CCEL) Other Operating Expenses (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Other Operating Expenses for 16 consecutive years, with $6.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Operating Expenses rose 225.14% to $6.3 million in Q4 2025 year-over-year; TTM through Nov 2025 was $12.5 million, a 42.88% increase, with the full-year FY2025 number at $11.6 million, up 42.48% from a year prior.
  • Other Operating Expenses was $6.3 million for Q4 2025 at Cryo Cell International, up from $2.0 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $18.2 million in Q4 2023 to a low of $1.9 million in Q4 2024.
  • A 5-year average of $3.4 million and a median of $2.4 million in 2024 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: surged 600.25% in 2023, then tumbled 89.37% in 2024.
  • Cryo Cell International's Other Operating Expenses stood at $3.6 million in 2021, then fell by 27.11% to $2.6 million in 2022, then soared by 600.25% to $18.2 million in 2023, then crashed by 89.37% to $1.9 million in 2024, then surged by 225.14% to $6.3 million in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Other Operating Expenses are $6.3 million (Q4 2025), $2.0 million (Q3 2025), and $2.0 million (Q2 2025).